Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yalda Yazdani has a total of 66 co-authors. Here are the top co-authors by number of shared publications:

  • Mehdi Dadashpour

    Cancer Research Center, Semnan University of Medical Sciences, Semnan, Iran

    3 shared publications
  • Elham Jokar

    Department of Medical Chemistry, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    2 shared publications
  • Hesam Ghafouri Kalajahi

    Department of Biotechnology, Institute of Science, Uskudar University, Istanbul, Turkey

    2 shared publications
  • Majid Eslami

    Research Center of Physiology, Neuroscience Research Institute, Semnan University of Medical Sciences, Semnan, Iran

    2 shared publications
  • Omid Gholizadeh

    Department of Bacteriology and Virology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

    2 shared publications
  • Pooneh Yasamineh

    Young Researchers and elite Club, Tabriz Branch, Islamic Azad University, Tabriz, Iran

    2 shared publications

Latest Publications

  • Open Access

    Massive Cholesteatoma With Facial Nerve, Middle and Posterior Fossa Dehiscence With Neck Extension

    by Yalda Yazdani, Nicole Kani, Artin S. Rastegar, Hamid R. Djalilian

    Cholesteatomas can grow aggressively within the temporal bone due to the accumulation of keratin. If not treated, they can destroy surrounding structures and, therefore, cause many comorbidities. Surgery is the mainstay of treatment. We present a case of massive cholesteatoma involving the facial nerve (FN) with extension into the neck around the FN. The patient underwent a planned multidisciplinary resection of the cholesteatoma without postoperative morbidity.


  • Open Access

    Review of: "Medical Education Gone Viral During the COVID-19 Pandemic"

    by Yalda Yazdani

    The manuscript titled _"Medical Education Gone Viral During the COVID-19 Pandemic"_ addresses a highly relevant topic, exploring the mental health impact of the COVID-19 pandemic on medical students and residents. The authors provide practical insigh...

  • Nanodiagnostics in global eradication of hepatitis C virus

    by Mohammad Darvishi, Reza Amiri, Emad Ghannad, Samir Mehrabkhani, Nassim Rastgar, Mahkameh Razaghi, Jaya Bansal, Mamata Chahar, Pranchal Rajput, Hossein Saffarfar, et al.


  • Open Access

    The State-of-the-Art Overview to Application of Deep Learning in Accurate Protein Design and Structure Prediction

    by Saber Saharkhiz, Mehrnaz Mostafavi, Amin Birashk, Shiva Karimian, Shayan Khalilollah, Sohrab Jaferian, Yalda Yazdani, Iraj Alipourfard, Yun Suk Huh, Marzieh Ramezani Farani, et al.

    In recent years, there has been a notable increase in the scientific community's interest in rational protein design. The prospect of designing an amino acid sequence that can reliably fold into a desired three-dimensional structure and exhibit the intended function is captivating. However, a major challenge in this endeavor lies in accurately predicting the resulting protein structure. The exponential growth of protein databases has fueled the advancement of the field, while newly developed algorithms have pushed the boundaries of what was previously achievable in structure prediction. In particular, using deep learning methods instead of brute force approaches has emerged as a faster and more accurate strategy. These deep-learning techniques leverage the vast amount of data available in protein databases to extract meaningful patterns and predict protein structures with improved precision. In this article, we explore the recent developments in the field of protein structure prediction. We delve into the newly developed methods that leverage deep learning approaches, highlighting their significance and potential for advancing our understanding of protein design.


  • Open Access

    The Personal Health Applications of Machine Learning Techniques in the Internet of Behaviors

    by Zahra Amiri, Arash Heidari, Mehdi Darbandi, Yalda Yazdani, Nima Jafari Navimipour, Mansour Esmaeilpour, Farshid Sheykhi, Mehmet Unal

    With the swift pace of the development of artificial intelligence (AI) in diverse spheres, the medical and healthcare fields are utilizing machine learning (ML) methodologies in numerous inventive ways. ML techniques have outstripped formerly state-of-the-art techniques in medical and healthcare practices, yielding faster and more precise outcomes. Healthcare practitioners are increasingly drawn to this technology in their initiatives relating to the Internet of Behavior (IoB). This area of research scrutinizes the rationales, approaches, and timing of human technology adoption, encompassing the domains of the Internet of Things (IoT), behavioral science, and edge analytics. The significance of ML in medical and healthcare applications based on the IoB stems from its ability to analyze and interpret copious amounts of complex data instantly, providing innovative perspectives that can enhance healthcare outcomes and boost the efficiency of IoB-based medical and healthcare procedures and thus aid in diagnoses, treatment protocols, and clinical decision making. As a result of the inadequacy of thorough inquiry into the employment of ML-based approaches in the context of using IoB for healthcare applications, we conducted a study on this subject matter, introducing a novel taxonomy that underscores the need to employ each ML method distinctively. With this objective in mind, we have classified the cutting-edge ML solutions for IoB-based healthcare challenges into five categories, which are convolutional neural networks (CNNs), recurrent neural networks (RNNs), deep neural networks (DNNs), multilayer perceptions (MLPs), and hybrid methods. In order to delve deeper, we conducted a systematic literature review (SLR) that examined critical factors, such as the primary concept, benefits, drawbacks, simulation environment, and datasets. Subsequently, we highlighted pioneering studies on ML methodologies for IoB-based medical issues. Moreover, several challenges related to the implementation of ML in healthcare and medicine have been tackled, thereby gradually fostering further research endeavors that can enhance IoB-based health and medical studies. Our findings indicated that Tensorflow was the most commonly utilized simulation setting, accounting for 24% of the proposed methodologies by researchers. Additionally, accuracy was deemed to be the most crucial parameter in the majority of the examined papers.


  • Enhanced anti-cancer effect of artemisinin- and curcumin-loaded niosomal nanoparticles against human colon cancer cells

    by Akram Firouzi Amandi, Elham Jokar, Majid Eslami, Mehdi Dadashpour, Mehdi Rezaie, Yalda Yazdani, Babak Nejati

    Colorectal cancer (CRC) is the third broadly identified cancer in the world. The ineffectiveness of colorectal cancer treatment is redundantly reported. Natural bioactive compounds have gained popularity in reducing the drawback of conventional anti-cancer agents. Curcumin (Cur) and Artemisinin (Art) are materials of a natural source that have been utilized to treat numerous kinds of cancers. Although the benefits of bioactive materials, their utilization is limited because of poor solubility, bioavailability, and low dispersion rate in aqueous media. Nano delivery system such as niosome can improve the bioavailability and stability of bioactive compounds within the drug. In current work, we used Cur–Art co-loaded niosomal nanoparticles (Cur–Art NioNPs) as an anti-tumor factor versus colorectal cancer cell line. The synthesized formulations were characterized using dynamic light scattering, scanning electron microscopy, and FTIR. The proliferation ability of the cells and expression of apoptosis-associated gene were MTT assay and qRT-PCR, respectively. Cur–Art NioNPs exhibited well distributed with an encapsulation efficiency of 80.27% and 85.5% for Cur and Art. The NioNPs had good release and degradation properties, and had no negative effect on the survival and proliferation ability of SW480 cells. Importantly, nanoformulation form of Cur and Art significantly displayed higher toxicity effect against SW480 cells. Furthermore, Cur–Art NioNPs increased Bax, Fas, and p53 gene expressions and suppressed Bcl2, Rb, and Cyclin D 1 gene expressions. In summary, these results display the niosome NPs as a first report of nano-combinational application of the natural herbal substances with a one-step fabricated co-delivery system for effective colorectal cancer.


  • Combination therapy with nivolumab (anti-PD-1 monoclonal antibody): A new era in tumor immunotherapy

    by Bahman Abedi Kiasari, Arash Abbasi, Nadia Ghasemi Darestani, Nasim Adabi, Arsalan Moradian, Yalda Yazdani, Golsa Sadat Hosseini, Nasrin Gholami, Sheida Janati


  • Open Access

    Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19

    by Saman Yasamineh, Hesam Ghafouri Kalajahi, Pooneh Yasamineh, Omid Gholizadeh, Hamed Rahmani Youshanlouei, Saeed Karimi Matloub, Masoud Mozafari, Elham Jokar, Yalda Yazdani, Mehdi Dadashpour

    The SARS-COV-2 virus has infected the world at a very high rate by causing COVID-19 disease. Nearly 507 million individuals have been infected with this virus, with approximately 1.2% of these patients being dead, indicating that this virus has been out of control in many countries. While researchers are investigating how to develop efficient drugs and vaccines versus the COVID-19 pandemic, new superseded treatments have the potential to reduce mortality. The recent application of mesenchymal stem cells (MSCs) in a subgroup of COVID-19 patients with acute respiratory distress has created potential benefits as supportive therapy for this viral contagion in patients with acute conditions and aged patients with severe pneumonia. Consequently, within this overview, we discuss the role and therapeutic potential of MSCs and the challenges ahead in using them to treat viral infections, with highlighting on COVID-19 infection. Graphical Abstract


  • Top Cited Papers

    A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system

    by Saman Yasamineh, Pooneh Yasamineh, Hesam Ghafouri Kalajahi, Omid Gholizadeh, Zahra Yekanipour, Hamed Afkhami, Majid Eslami, Amir Hossein Kheirkhah, Milad Taghizadeh, Yalda Yazdani, et al.